Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

Involutional Osteoporosis Clinical Trial

Official title:
Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of ONO-5920 in patients with involutional osteoporosis.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00212628
Study type	Interventional
Source	Ono Pharmaceutical Co. Ltd
Contact
Status	Completed
Phase	Phase 3
Start date	June 2004

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00212719` - Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan	Phase 3
Active, not recruiting	`NCT02063854` - A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets	Phase 2/Phase 3
Completed	`NCT02066376` - A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets	Phase 2/Phase 3
Completed	`NCT00212667` - Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan	Phase 3